Interestingly, as with CXCL8, both MOF preparations reduced ET-1 release, again MIL-89 PEG was more effective than authentic MIL-89, in endothelial cells from both control donors as well as from patients with PAH. Here, EDN1 is linked to pulmonary arterial hypertension.